NCT06658405 2026-03-18
HPV2
Centre Oscar Lambret
Phase 2 Recruiting
Clinical Trials
13 trialsNCT04206813 2026-01-27
An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen
Boston Medical Center
Phase 4 Active not recruiting
NCT03023631 2025-11-18
Gardasil 9 Vaccine in Preventing HPV Infection in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
M.D. Anderson Cancer Center
Phase 4 Active not recruiting
NCT05087849 2025-10-02
Intralesional HPV Vaccine for Condylomata
University of California, San Francisco
Phase 1/2 Completed
NCT04982614 2025-08-24
HPV Vaccination in HIV Infected and HIV Uninfected Adolescents in Eswatini
Columbia University
Phase 4 Completed
NCT05266898 2025-04-18
AGO-Gard
Louisiana State University Health Sciences Center in New Orleans
Phase 4 Recruiting
NCT01824537 2025-03-19
TRAP-HPV
McGill University
Phase 4 Completed
NCT06681636 2024-11-08
HPV9vxFSW
National Institute of Hygiene and Epidemiology, Vietnam
Phase 2 Not yet recruiting
NCT06536855 2024-08-05
Faster Elimination of HPV Infection and Cervical Cancer Using Concomitant HPV Vaccination and HPV Screening: A Demonstration Project in Rwanda
Rwanda Biomedical Centre
Phase 4 Not yet recruiting
NCT04270773 2024-07-10
9-VPH-MVIH
University Hospital Virgen de las Nieves
Phase 4 Active not recruiting
NCT03051516 2024-02-28
HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions
Fred Hutchinson Cancer Center
Phase 4 Terminated
NCT04459221 2022-03-02
PROM SSCOL
Centre Hospitalier Universitaire de la Réunion
Phase 4 Completed
NCT01492582 2021-10-27
Vaccine Therapy in Preventing Human Papillomavirus Infection in Younger Cancer Survivors
University of Alabama at Birmingham
Phase 2 Completed